You are here

  • Home
  • Archive
  • Volume 73, Issue 3
  • Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

Article info

Article menu
Clinical and epidemiological research
Extended report
Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

Authors

  • Cécile Gaujoux-Viala Department of Rheumatology, Nîmes University Hospital; EA 2415, Montpellier I University, Nîmes, France PubMed articlesGoogle scholar articles
  • Jackie Nam Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Sofia Ramiro Department of Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Department of Rheumatology, Hospital Garcia de Orta, Almada, Portugal PubMed articlesGoogle scholar articles
  • Robert Landewé Department of Clinical Immunology & Rheumatology, Academic Medical Center/University of Amsterdam & Atrium Medical Center, Heerlen, The Netherlands PubMed articlesGoogle scholar articles
  • Maya H Buch Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Josef S Smolen Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria 2nd Department of Medicine, Hietzing Hospital Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Laure Gossec Department of Rheumatology, UPMC Univ Paris 06, GRC-UPMC 08 (EEMOIS); AP-HP, Pitié Salpêtrière Hospital, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Cécile Gaujoux-Viala, Service de Rhumatologie, CHU de Nîmes Carémeau, Place du Professeur Robert Debré, 30029 Nîmes cedex 9, France; cecilegaujouxviala{at}yahoo.fr
View Full Text

Citation

Gaujoux-Viala C, Nam J, Ramiro S, et al
Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
Annals of the Rheumatic Diseases 2014;73:510-515.

Publication history

  • Received September 9, 2013
  • Revised November 2, 2013
  • Accepted December 11, 2013
  • First published January 6, 2014.
Online issue publication 
November 02, 2019

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/